19 May 2022 , 07:57 AM
In terms of business verticals, Jubilant Ingrevia saw robust sales growth across specialty chemicals, nutrition and chemical intermediates. Specialty chemicals grew on healthy demand while chemical intermediates gained from robust demand for products from the agrochemicals and pharma industry.
Board declared final dividend of Rs2.50 per share. EBITDA margins for the quarter tapered from 21.1% to 18.2% on yoy basis.
For Q4FY22, the EBIT from specialty chemicals and nutrition products grew sharply yoy while the EBIT from chemical intermediates business fell sharply by -57.2% yoy.
On yoy basis, material costs doubled while power costs were up 3-fold. Net margins were 5.29% in Q4FY22 quarter compared to 8.53% in Q4FY21. NPM was lower as compared to 10.03% in Q3FY22.
Financial highlights for Mar-22 compared yoy and sequentially
Jubilant Ingrevia | |||||
Rs in Crore | Mar-22 | Mar-21 | YOY | Dec-21 | QOQ |
Total Income (Rs cr) | ₹ 1,295.75 | ₹ 684.13 | 89.40% | ₹ 1,286.48 | 0.72% |
Net Profit (Rs cr) | ₹ 68.59 | ₹ 58.36 | 17.53% | ₹ 129.07 | -46.86% |
Diluted EPS (Rs) | ₹ 4.30 | ₹ 5.20 | ₹ 8.12 | ||
Net Margins | 5.29% | 8.53% | 10.03% |
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.